From pg 6 of the 2019 Annual Report .....
"Work to date has moved from the demonstration of our technology with a group of multinational companies in a range of industries, to that of
active engagement in specific trials related to the application of the FRG technology into their products."
From today's announcement.....
"As has been advised to the market, during the past 12 months the Company has engaged with large scale multinational corporations and
has received valuable feedback from these organisations."
That usually means something along the lines of 'thanks but no thanks' IMHO.
All the 'hints' from the company had been along the lines of secrecy of dealing with these OEMs as the FRG tech gets included into some products. Receiving "valuable feedback", is not what investors were after, nor seeking for the technology. Deals were what was promoted and pretty much promised, but they are again lacking.
Why??
That is the question investors should be asking themselves. Why is it so difficult to get this tech into any product?? Nearly 3 years ago the following statement was made about FRG/Bluemist ....
"Given that the FGR technology is highly advanced, the path to development of the Bluemist (R) product portfolio has been shortened and
the focus is now on final design, product packaging, cost and in situ performance validation."
https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01932237There are a few companies that had huge growth in share price a few months ago by merely mentiong they were working on Covid solutions, so what work has Purifloh done on Covid?? Not mentioned in today's update at all. Really?? They haven't bothered to do some type of study of the tech into it's effectiveness against Covid. Why Not??
My opinion that I mentioned a few months ago was that a pulsed corona discharge device, that the FRG appears to be, is not unique, in the way that some investors believe.
There are already other pulsed corona discharge devices on the market in various roles, ozone generators, hydroxyl generators, UV generators (and combinations of them).
The current Mcap is ~$50M. Why does this company, that is now running low on cash without any income, deserve a MCap anywhere near this level??
This question remains very relevant when considering they are in the same position as nearly 3 years ago when the Mcap was ~$15M.
